USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; text-indent: 35.4pt; line-height: 200%; text-align: justify; mso-pagination: none; mso-layout-grid-align: none;"><span style="mso-ansi-language: EN-GB;" lang="EN-GB"><span styl...
Saved in:
| Main Authors: | Claudio Ucciferri, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Jacopo Vecchiet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2010-02-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/5582 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Paola Mancino, et al.
Published: (2010-03-01) -
Cardiac toxicity associated with HCV direct antiviral agents
by: Claudio Ucciferri, et al.
Published: (2018-10-01) -
Sarcoidosis during HCV antiviral therapy
by: Emanuela De Santis, et al.
Published: (2014-08-01) -
Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01) -
Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)